{"id":4628,"date":"2014-11-26T13:00:49","date_gmt":"2014-11-26T13:00:49","guid":{"rendered":"http:\/\/www.scienceofdme.org\/?p=4628"},"modified":"2014-11-25T18:35:18","modified_gmt":"2014-11-25T18:35:18","slug":"antiangiogenic-agent-aflibercept-approved-in-japan-for-treatment-of-diabetic-macular-edema","status":"publish","type":"post","link":"https:\/\/www.scienceofdme.org\/es\/antiangiogenic-agent-aflibercept-approved-in-japan-for-treatment-of-diabetic-macular-edema\/","title":{"rendered":"(English) Antiangiogenic Agent Aflibercept Approved in Japan for Treatment of Diabetic Macular Edema"},"content":{"rendered":"<p><\/p>","protected":false},"excerpt":{"rendered":"","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":[],"categories":[1],"tags":[],"_links":{"self":[{"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/posts\/4628"}],"collection":[{"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/comments?post=4628"}],"version-history":[{"count":1,"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/posts\/4628\/revisions"}],"predecessor-version":[{"id":4629,"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/posts\/4628\/revisions\/4629"}],"wp:attachment":[{"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/media?parent=4628"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/categories?post=4628"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.scienceofdme.org\/es\/wp-json\/wp\/v2\/tags?post=4628"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}